Veritas Pharma Provides Corporate Update on Q1 2018
21 févr. 2018 03h10 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an official corporate...
Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders
04 janv. 2018 17h24 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an update to its...
Veritas Pharma Initiates Cancer Research with Dr. Dmitri Petchkovski
14 nov. 2017 16h15 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT); (OTC:VRTHF); and (Frankfurt:2VP), (“Veritas” or the “Company”) announces that it has initiated a cancer...